Visit our COVID update page.
Edward James Rozhon LinkedIn
"The persistence of COVID-19 and the continued emergence of new viruses highlight the importance of learning from the present viral pandemic as well as past ones to better prepare for future pandemics."
EDWARD ROZHON, Ph.D., chair of the Biotechnology and Clinical Trials Design and Management programs, has had a long career in the biopharmaceutical industry as a contributor to the development of drugs to treat viral and autoimmune diseases, as well as several types of cancer. He has worked in both nonclinical and clinical areas of drug development, in the global pharmaceutical and biotech industry, in a contract research organization to support clinical research as well as in academia. He retired from Genentech in 2014 as a senior manager of clinical operations for autoimmune, infectious, and ophthalmologic diseases. On completing his doctorate at Indiana University, he pursued post-doctoral training in neurovirology at the University of Alabama School of Medicine and at Northwestern University School of Medicine and was subsequently appointed to a faculty position in microbiology and immunology. He has taught courses in drug development and virology at UCSC Extension since 2001. He currently serves as chair of the UCSC Extension certificate program advisory boards for Biotechnology and for Clinical Trials Design and Management.